SARS CoV 2 News and Research

RSS

Consistent use of face masks slows the spread of COVID-19

The use of face masks to help slow the spread of COVID-19 has been widely recommended by health professionals.

25 Nov 2020

Researchers develop lung-on-chip model to study the body’s response to early TB

Scientists have developed a lung-on-chip model to study how the body responds to early tuberculosis (TB) infection, according to findings published today in eLife.

25 Nov 2020

SARS-CoV-2 versus Zika: Comparing and contrasting the flow of research

An interesting study published on the preprint server medRxiv in November 2020, dealing not with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that is the cause of the COVID-19 pandemic, but with the publications that have appeared as a consequence of the outbreak, comparing them with the similar trove of publications that followed the Zika virus outbreak in 2016.

25 Nov 2020

Bariatric surgery linked to lower risk of hospital and intensive care unit admission

A Cleveland Clinic study shows that among patients who have obesity and who tested positive for COVID-19, a past history of bariatric surgery was significantly associated with a lower risk of hospital and intensive care unit admission.

24 Nov 2020

Austrian study shows robust antibody response to SARS-CoV-2 for over 6 months

In the face of discouraging news about the resurgence of COVID-19, some reports offer hope of protection in the face of a robust and persistent immune response. In an encouraging report, an Austrian preprint appearing on the medRxiv server in November 2020 suggests a high level of durable immunity to SARS-CoV-2 over at least six months.

24 Nov 2020

A review of Traditional Chinese herbal medicine in management of COVID-19

Now researcher have summarized the experiences with the use of traditional Chinese herbal medicines for the management of COVID-19. Their study titled, “Traditional Chinese herbal medicine at the forefront battle against COVID-19: Clinical experience and scientific basis,” was published in the January 2021 issue of the journal Phytomedicine.

24 Nov 2020

Mefloquine shows potential as anti-SARS-CoV-2 drug

A team of scientists from Japan has identified the approved anti-material drug, mefloquine, as a potential candidate to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Specifically, mefloquine has been shown to prevent the entry of SARS-CoV-2 into host cells and reduce the viral load in vitro.

24 Nov 2020

Disproportionate COVID-19 mortality in England linked to non-white ethnicity and poverty

In a paper published on the preprint server medRxiv, researchers from various departments of Imperial College London, UK, discuss how they analyzed mortality data of individuals 40 years and above in local communities in England to determine local variations in increased mortality during the first wave of the pandemic – between 1 March and 31 May 2020 - and to identify the community factors associated with these mortality patterns.

24 Nov 2020

Protection of upper respiratory tract will require vaccines that mimic natural infection by SARS-CoV-2

Recently, a team of researchers studied the transmission modes of SARS-CoV-2 and the protection against re-infection in ferret models in work published on the preprint server, bioRxiv.

24 Nov 2020

Air quality could influence the virulence of COVID-19 disease

The correlation between the high concentration of fine particles and the severity of influenza waves is well known to epidemiologists.

24 Nov 2020

Mild COVID-19 disease may trigger long-term immunity

Researchers in the United States have conducted a study showing that individuals who have recovered from mild coronavirus disease 2019 (COVID-19) developed sustained protective immune memory against the causative agent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

24 Nov 2020

Vaping does not appear to pose any significant additional risk of SARS-CoV-2 transmission

Researchers in Mexico, New Zealand and Italy have conducted a modeling study suggesting that the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) being transmitted via indoor vaping is not significantly higher than the risk associated with other types of expiration.

24 Nov 2020

Sex steroids may play a protective role in COVID-19, shows study

A new paper from a UIC researcher shows evidence that suggests sex steroids may play a role in protecting against COVID-19 symptoms.

24 Nov 2020

Digital warm-start CRISPR assay enables sensitive quantitative detection of SARS-CoV-2 in clinical samples

In a recent medRxiv* preprint paper, researchers from the University of Connecticut Health Center in the United States unveil their digital warm-start CRISPR (WS-CRISPR) method for stringent and sensitive quantitative detection of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in clinical samples of patients with coronavirus disease (COVID-19).

24 Nov 2020

Penn State researcher to study how vitamin D regulates host immunity to viral infection

Funding from the National Institutes of Health will enable a Penn State researcher to study whether vitamin D supplementation could help people ward off or reduce symptoms caused by COVID-19.

24 Nov 2020

The role of micro-RNA in SARS-CoV-2 infection and COVID-19

A team of researchers based in Iran have explored the role of micro-RNA in COVID-19. Their study titled, “The emerging role of microRNAs in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection,” was published in the latest issue of the journal International Immunopharmacology.

24 Nov 2020

SARS CoV 2 News and Research

Consistent use of face masks slows the spread of COVID-19

Researchers develop lung-on-chip model to study the body’s response to early TB

SARS-CoV-2 versus Zika: Comparing and contrasting the flow of research

Bariatric surgery linked to lower risk of hospital and intensive care unit admission

Austrian study shows robust antibody response to SARS-CoV-2 for over 6 months

A review of Traditional Chinese herbal medicine in management of COVID-19

Mefloquine shows potential as anti-SARS-CoV-2 drug

Disproportionate COVID-19 mortality in England linked to non-white ethnicity and poverty

Protection of upper respiratory tract will require vaccines that mimic natural infection by SARS-CoV-2

Air quality could influence the virulence of COVID-19 disease

Mild COVID-19 disease may trigger long-term immunity

Vaping does not appear to pose any significant additional risk of SARS-CoV-2 transmission

Sex steroids may play a protective role in COVID-19, shows study

Digital warm-start CRISPR assay enables sensitive quantitative detection of SARS-CoV-2 in clinical samples

Penn State researcher to study how vitamin D regulates host immunity to viral infection

The role of micro-RNA in SARS-CoV-2 infection and COVID-19

Scientists show SARS-CoV-2's viral replication with 3D integrative imaging

Aprotinin inhibits SARS-CoV-2 entry and replication in cells cultures

Technology used for screening liquids can be adapted to provide rapid COVID-19 testing

SARS-CoV-2's RNA folding structures are potential therapeutic targets, study finds

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News